MedWatch

Rebien despite EMA disappointment: ”We can be happy”

Though Denmark’s special envoy, Lars Rebien Sørensen, is disappointed that EMA will not move to Copenhagen, he is happy that the Danish capital is now back on the map as a competent life science hub. And, unlike the Danish government, he does not blame the Swedes.

Photo: Finn Frandsen/POLFOTO/Arkiv

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

FDA vil lette vejen til markedet for medicin mod Alzheimers

De amerikanske lægemiddelmyndigheder vil lempe kravene til godkendelse af lægemidler mod Alzheimers, fordi forskning viser, at sygdommen indtræder tidligere end hidtil antaget. Lægemiddeludviklingen og godkendelse heraf derfor skal tilpasses derefter, mener FDA-boss Scott Gottlieb.

Related articles